ropivacaine + mepivacaine

Ropivacaine + mepivacaine is a combination of two amide-type local anesthetics used in regional anesthesia, particularly for nerve blocks during surgical procedures. Ropivacaine is characterized by its long duration of action and lower cardiotoxicity compared to bupivacaine, while mepivacaine has a faster onset but shorter duration. The rationale for combining these agents is to leverage the rapid onset of mepivacaine with the prolonged analgesic effect of ropivacaine, aiming to provide both quick and sustained anesthesia. Both drugs act by blocking voltage-gated sodium channels on neuronal membranes, thereby inhibiting nerve impulse conduction and producing local numbness or loss of sensation[1][2][4]. Clinical studies have shown that simultaneous or sequential administration does not significantly alter efficacy outcomes compared to using either agent alone[1][5].